Inspira Technologies’ AI-Powered Blood Sensor Surpasses Expectations with Positive Clinical Data
Inspira Technologies’ AI-Powered Blood Sensor Surpasses Expectations with Positive Clinical Data PESG Research has released an update following the groundbreaking results from a clinical evaluation: Inspira Technologies (NASDAQ: IINN) has reported outstanding outcomes from its HYLA blood sensor study, achieving…
PureHealth Partners with Abu Dhabi Early Childhood Authority for Child Healthcare Solutions
PureHealth Partners with Abu Dhabi Early Childhood Authority for Child Healthcare Solutions PureHealth has announced a strategic partnership with the Abu Dhabi Early Childhood Authority (ECA) to improve health outcomes for children throughout the UAE. The collaboration aims to enhance…
Guardant Health Partners to Boost Colon Cancer Screening in Underserved Communities
Guardant Health Partners to Boost Colon Cancer Screening in Underserved Communities Guardant Health, Inc. (Nasdaq: GH), a leader in precision oncology, has announced a collaboration with Dak Prescott’s Faith Fight Finish Foundation and Partners in Wellness, a mobile cancer screening…
Andlauer Healthcare Group Announces Nova Pack-NowPac Joint Venture
Andlauer Healthcare Group Announces Nova Pack-NowPac Joint Venture Andlauer Healthcare Group Inc. (TSX: AND) (“AHG” or the “Company”) announced today the launch of a new joint venture that will combine its packaging subsidiary, Nova Pack Ltd. (“Nova Pack”), with NowPac…
Nelson Labs Unveils Rapid Sterility Testing to Speed Up Results
Nelson Labs Unveils Rapid Sterility Testing to Speed Up Results Nelson Labs, a Sotera Health company, has launched an innovative solution for product-sterility testing through rapid microbiological methods (RMMs) at three of its laboratory sites in the United States and…
iMH Launches First Private Mental Health Hospital in Queensland
iMH Launches First Private Mental Health Hospital in Queensland Queensland’s first private mental health hospital, Nundah Private Hospital, has officially opened, addressing significant gaps in Australia’s mental health system. Operated under a joint venture between Aurora Healthcare and Amplar Health,…
Baxter Launches Voalte Linq Device with Scotty Assistant at HIMSS25
Baxter Launches Voalte Linq Device with Scotty Assistant at HIMSS25 Baxter International Inc. (NYSE: BAX), a global leader in medical technology, unveiled its Voalte Linq device powered by the Scotty assistant at the 2025 HIMSS Global Healthcare Conference. The Voalte…
Peach State Health Plan and Centene Foundation Invest in Atlanta Housing Development
Peach State Health Plan and Centene Foundation Invest in Atlanta Housing Development Peach State Health Plan, a care management organization serving residents across Georgia, and the Centene Foundation, the philanthropic arm of Centene Corporation, have announced their partnership with Atlanta…
Wellvana Purchases CVS Health’s MSSP Business
Wellvana Purchases CVS Health’s MSSP Business Wellvana, a leader in value-based care enablement, has announced the acquisition of CVS Health’s Medicare Shared Savings Program (MSSP) business. The deal, an all-stock transaction, also provides CVS Health with a strategic minority stake…
Bunkerhill Health and Cleerly Partner to Enhance Noninvasive Cardiovascular Care
Bunkerhill Health and Cleerly Partner to Enhance Noninvasive Cardiovascular Care Bunkerhill Health, a leader in AI-driven early disease detection, has partnered with Cleerly, a pioneer in advanced cardiovascular imaging, to expand access to their technologies for detecting coronary artery disease…
FDA Accepts Gazyva sBLA for Lupus Nephritis Treatment
FDA Accepts Gazyva sBLA for Lupus Nephritis Treatment Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for Gazyva® (obinutuzumab) in the treatment of lupus…
New Data Supports DNA Vaccine Delivery via Vaxxas’ HD-MAP Technology
New Data Supports DNA Vaccine Delivery via Vaxxas’ HD-MAP Technology Vaxxas, a clinical-stage biotechnology company specializing in a novel vaccination platform, announced today the publication of data validating the effectiveness of its high-density microarray patch (HD-MAP) technology for delivering nucleic…